Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

NCT06842589 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Multi-Drug Resistant Nephrotic Syndrome
CAR-T Cell Therapy

Interventions

BIOLOGICAL: anti-CD19 CAR-T cells

Sponsor

The Children's Hospital of Zhejiang University School of Medicine